Latest portfolio news

WhiteLab Genomics expands to the US

Efficacy of Mika: A Digital Therapeutic for distress reduction in cancer patients

Risklick joins Debiopharm Innovation Fund Portfolio

Yonalink Partners with AI4LUNGS

BC Platforms and NTT Group announce exclusive collaboration

Genialis uses machine learning to personalize cancer treatment outcomes

New Genialis RNA biomarker accurately predicts KRAS outcomes in lung cancer patients

Nucleai and GoPath Diagnostics announce strategic collaboration

Merck’s M Ventures supports Nucleai’s spatial AI biomarker technology for clinical trial enrolment